Next Article in Journal
Characterization of Molecular Species and Anti-Inflammatory Activity of Purified Phospholipids from Antarctic Krill Oil
Previous Article in Journal
Secondary Metabolites from the Marine Sponges of the Genus Petrosia: A Literature Review of 43 Years of Research
Previous Article in Special Issue
New Hydroquinone Monoterpenoid and Cembranoid-Related Metabolites from the Soft Coral Sarcophyton tenuispiculatum
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Targeted Isolation of Xenicane Diterpenoids From Taiwanese Soft Coral Asterospicularia laurae

1
Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804351, Taiwan
2
Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807378, Taiwan
3
Graduate Institute of Natural Products, Center for Natural Product Research and Development, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807378, Taiwan
4
Department of Biomedical Science and Environmental Biology, PhD Program in Life Science, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
5
Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
6
Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan
7
Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan
8
Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan
9
Division of Chinese Materia Medica Development, National Research Institute of Chinese Medicine, Taipei 11221, Taiwan
10
Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan
11
Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944401, Taiwan
12
Department of Physical Therapy, Tzu-Hui Institute of Technology, Pingtung 92641, Taiwan
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2021, 19(3), 123; https://doi.org/10.3390/md19030123
Submission received: 3 February 2021 / Revised: 14 February 2021 / Accepted: 23 February 2021 / Published: 25 February 2021
(This article belongs to the Special Issue Bioactive Natural Products from Soft Corals)

Abstract

:
Application of LC-MS/MS-based molecular networking indicated the ethanol extract of octocoral Asterospicularia laurae is a potential source for the discovery of new xenicane derivatives. A natural product investigation of this soft coral resulted in the isolation of four new xenicane diterpenoids, asterolaurins O–R (14), together with six known compounds, xeniolide-A (5), isoxeniolide-A (6), xeniolide-B (7), 7,8-epoxyxeniolide-B (8), 7,8-oxido-isoxeniolide-A (9), and 9-hydroxyxeniolide-F (10). The structures of isolated compounds were characterized by employing spectroscopic analyses, including 2D-NMR (COSY, HMQC, HMBC, and NOESY) and high-resolution electrospray ionization mass spectrometry (HRESIMS). Asterolaurin O is the first case of brominated tricarbocyclic type floridicin in the family Xeniidae. Concerning bioactivity, the cytotoxic activity of those isolates was evaluated. As a result, compounds 1 and 2 demonstrated a selective cytotoxic effect against the MCF-7 cell line at IC50 of 14.7 and 25.1 μM, respectively.

1. Introduction

Marine organisms such as sponges, soft corals, tunicates, and alga were regarded as plentiful sources of bioactive molecules, and many marine natural products or their derivatives have been used as drug candidates. Over the past 40 years, nearly 59% of antitumor agents have come from small-molecule natural products or inspired from natural sources [1]. So far, natural product investigations of Asterospicularia sp. resulted in a new pentahydroxylated sterol named 24ξ-Methyl-5α-cholestane-3β,5,6β,22R,24-pentol 6-acetate together with 14 new xenicane-type diterpenoids (13-epi-9-deacetoxyxenicin and asterolaurins A–M) [2,3,4,5,6,7]. Among those isolates, 13-epi-9-deacetoxyxenicin exhibited strong cytotoxicity against P388D1 mouse lymphoma cells with an IC50 of 2.17 μM [3], asterolaurin A exhibited moderate cytotoxicity against HepG2 cells with an IC50 of 8.9 µM, asterolaurin D showed inhibition of elastase release and superoxide anion generation with IC50 values of 18.7 and 23.6 µM, respectively [4], asterolaurin L showed moderate cytotoxic activity against HEp-2, Daoy, MCF-7, and WiDr tumor cell lines, with ED50 values of 11.8, 17.8, 11.7, and 17.4 μg/mL, respectively [5]. Moreover, 13-epi-9-desacetylxenicin, first isolated from Xenia Novae-Britanniae, also yielded from A. laurae, demonstrated significantly cytotoxic against Molt 4 (human T lymphoblast; acute lymphoblastic leukemia), K562 (human blood chronic myelogenous leukemia), Sup-T1 (Human T cell lymphoblastic lymphoma), and U937 (Human Caucasian histiocytic lymphoma) cells with IC50 values of 1.30, 1.19, 3.17, 2.45 μM, respectively [7]. LC-MS/MS-based metabolite profiling has gradually become the mainstream of modern natural product investigation. This method provides a quick and visible spectrum for natural product de-replication [8,9] and targeted isolation [10]. As an assistant of this approach, A. laurae., collected in Orchid Island, Taiwan, were evaluated, and it demonstrated an abundance of xenicane-type diterpenes. As stated above, xenicane-type diterpenes could be potential sources of new antitumor agents; therefore, our continuing marine natural product investigation of bioactivity substances focuses on it. This article reports the isolation, structure determination, and bioactivity evaluation of the marine metabolites isolated from A. laurae.

2. Results and Discussion

The ethanol extract of A. laurae was partitioned between EtOAc and H2O to obtain an EtOAc-soluble layer. This layer was further partitioned between hexanes and 75% MeOH(aq) to remove the low polarity metabolites. The 75% MeOH layer was analyzed by the LC-MS/MS (negative ion mode). The MS/MS data were uploaded to the Global Natural Products Social Molecular Networking (GNPS, https://gnps.ucsd.edu/ (accessed on 3 February 2021)) website, and the output data were mapped to create correlated clusters.
A cluster (Figure 1) with molecular weights of nodes between 276 and 384 was found to have the MS/MS fragment peaks of xenicane-type diterpenes (Figure S45), suggesting this group of metabolites could be xenicane-type diterpenes. A de-replication work was subsequently executed by comparing those molecular weights of nodes to known xenicanes. This investigation indicated that A. laurae should be a rich sources of new xenicane-type diterpenes.
Four new compounds named asterolaurins O–R (14) along with six known xenicane diterpenoids, xeniolide-A (5) [11], isoxeniolide-A (6) [12], xeniolide-B (7) [11], 7,8-epoxyxeniolide-B (8) [13], 7,8-oxido-isoxeniolide-A (9) [11], and 9-hydroxyxeniolide-F (10) [14] (Figure 2) were isolated and purified by successive silica gel, Sephadex LH-20, and semi-preparative normal-phase and reversed-phase high performance liquid chromatography (HPLC) columns. Their structures were further elucidated by spectroscopic data and compared with the relative literature.
Asterolaurin O (1) was obtained as an amorphous, colorless gum. The infrared (IR) data indicated the presence of hydroxy (3424 cm−1) and ester carbonyl (1719 cm−1) functionalities. The presence of one bromine atom in 1 was apparent from the isotopic pattern in a 1:1 ratio observed for the quasi-molecular ion peaks at 451.11 [M + Na]+ and 453.12 [M +Na+ 2]+, accompanied by an [M + H]+ fragment at m/z 429.04 and 431.11, and its molecular formula was assigned as C20H29BrO5 by high-resolution ESIMS (m/z 451.10903 [M + Na]+, calculated for C20H29BrNaO5, 451.10906), implying 6 degrees of unsaturation. The 13C NMR and distortionless enhancement by polarization transfer (DEPT) spectra showed the presence of four olefinic carbons (δc 122.3 (d), 129.7 (d), 137.0 (c), and 146.2 (d)) and a lactone carbonyl δc 176.9 (s), suggesting that 1 was tricyclic. Detailed inspection of 1H and 13C NMR spectra of 1 (Table 1) disclosed signals characteristic for the A ring and the side chain were similar to those in florlide A [15], such as two singlet methyl protons (δH 1.30 x2) on a quaternary carbon (δC 71.3, C-15) substituted by a hydroxyl group, were assigned to H-16 and H-17. Moreover, the diene resonance due to H-13 (δH 6.34, dd, J = 11.1, 15.3 Hz) was correspondingly coupled to H-12 (δH 6.15, d, J = 11.1 Hz) and H-14 (δH 5.94, d, J = 15.3 Hz). Additionally, the chemical shifts of diene protons combined with the appearance of lactone carbonyl signal, as well as an AB spin system oxymethylene at δH 4.44 (1H, d, J= 12.0 Hz) and 5.06 (1H, br d, J = 12.0 Hz) implied that 1 should belong to a xeniolide B type pyran-cyclononane diterpenoid. Analysis of the 1H-1H COSY and HMBC spectra (Figure 3) corroborated the plane structure of 1. COSY correlations between two de-shielded protons H-8 (δH 4.09, d, 5.7; δC 72.9) and H-9 (δH 4.37, td, 5.7, 8.7; δC 75.1), the latter one also correlating to H-10 (δH 2.22, d, 5.7 and 2.24, d, 8.7; δC 39.8), were observed. The other spin system for H-11a/H-4a/H-5/H-6 from the COSY spectrum as well as HMBC correlations from Me-18 to C-6, C-7, C-8, and C-19, from isolated AB quartet protons H2-19 to C-7, C-11, and C-11a, from H-11a to C-1, C-11, and C-19 had established the bicyclic [4.3.1] ring system in 1. Two hydroxyl groups were positioned at C-8 and C-11 due to some similar bicyclic [4.3.1] analogues being yielded from Xenia species, and possessed the same substitutes [15,16,17,18,19]. Thus, the residue bromine should be attached at the C-9 position to meet the data from NMR and mass, and the gross structure of 1 was identified. The relative stereochemistry of compound 1 was established from NOESY correlations (Figure 3) and by comparison of its spectroscopic data to those of xeniolide analogues. The E geometry of the Δ13 double bond was established by the large coupling constant observed between H-13 and H-14 (J = 15.3 Hz). Furthermore, the geometry of the olefinic bond between C-4 and C-12 was concluded to be E, based on a strong NOESY correlation between H-4a (δH 3.18) and H-13 was observed. The large coupling constant (J = 12.0 Hz) between H-4a and H-11a allowed us to assume H-4a was α-orientation, whereas H-11a was β-orientation. The NOESY correlations of H-19A/H-11a/H-19β/Me-18 revealed H2-19 and Me-18 were both on the β-side of 1. Based on the above results, we could deduce that the stereochemistry of ring junctions (C-7 and C-11) in the bicyclic [4.3.1] scaffold of 1 were the same with those of floridicins [17]. The NOESY correlations of H-10α/H-4a/H-6α/H-8 revealed those protons were on the α-side of 1. On the contrary, the NOESY correlations of H-6β/Me-18/H-19β/H-9/H-10β revealed that those protons were on the β-side of 1. Therefore, the structure of 1 (asterolaurin O) was assigned as 9α-bromo-florlide A on the basis of the above results. This structure represents the first case of brominated tricarbocyclic floridicin among the plethora of diterpenoid compounds already reported from corals.
Asterolaurin P (2) was obtained as a pale yellowish amorphous gum with a molecular formula of C21H30O4 with 7 indices of hydrogen deficiency, as established based on its 13C NMR data and an HRESIMS pseudo-molecular ion peak at m/z 369.20379 [M + Na]+ (calcd for 369.20363). The IR spectrum indicated absorption bands due to hydroxyl (3454 cm−1) and ester carbonyl (1727 cm−1) functionalities, whereas the UV (λmax 237 and 215 nm) also supported a conjugated diene system. The structure of 1 was completely identified by a combination of 1D and 2D nuclear magnetic resonance experiments. The carbon resonances at δC 126.6 (CH), 131.8 (CH), 133.2 (qC),134.6 (qC), 137.3 (CH), and 146.4 (CH) in the 13C NMR and DEPT spectra (Table 1) suggested the presence of three double bonds, and the quaternary carbon signal at δC 149.5 along with the methylene olefinic carbon signal at δC 115.3 indicated the presence of an exo-methylene double bond. Moreover, an ester δC 171.4 (qC) was also observed that implied that 2 was a bicyclic compound. The 1H NMR spectrum (Table 1) confirmed the presence of an exo-methylene double bond by two singlet signals at δH 4.95 and 5.06. Three spin systems (I-III, Figure 1) were deduced from combined 1H-1H COSY (Figure 4) and HSQC spectra of 1. Fragment I consisted of a sequence of three double bond methines, and fragment II started from an oxymethylene (δH 3.63, 4.11) and ended with the relative deshielding methylene (δH 2.19) as well as fragment III, which included a carbinolic proton (δH 4.72; δC 67.9) and was correlated with the fourth double bond methine (δH 5.26; δC 131.8) and with allylic methylene (δH 2.34 and 2.50). These subunits were connected through key HMBC correlations (Figure 4) of H-1 (δH 3.63, 4.11) with C-3 (δC 171.4) and C-4a (δC 52.0), of H-12 (δH 6.53) with C-4a, of protons H-13 (δH 6.76), H-14 (δH 5.98), Me-16 (δH 1.30), and methoxy (δH 3.18) with C-15 (δC 76.5), of Me-18 (δH 1.70) with C-6 (δC 40.9), C-7(δC 133.2), and C-8 (δC 131.8), as well as of exomethylene protons (δH 4.95, 5.06) with C-10 (δC 46.2), C-11(δC 49.5), and C-11a (δH 51.1). Based on the above results, the gross structure of asterolaurin P could be constructed. The coupling constant (J = 11.0 Hz) between H-4a and H-11a suggested a trans ring junction, which implied that H-4a was α-oriented. The Z geometry of the Δ4,12 double bond was deduced on the basis of the NOESY (Figure 4) cross-peaks H-12/H-4a, and the chemical shift of C-4a in 1 was shifted -9.8 ppm, compared with its Δ4,12 E isomer, due to an γ effect of C-13 [7]. Additionally, the chemical shift of H-13 at δH 6.76, which is downfield-shifted to the corresponding E isomer (δH 6.40) due to an anisotropic effect, occurred with the carbonyl group. Moreover, the E geometry of the Δ13 double bond was established by the large coupling constant observed between H-13 and H-14 (J = 15.7 Hz). On the other hand, the Δ7 double bond could be determined as an E configuration according to the 13C chemical shift of Me-18, which was 17.3 rather than at 22-25 for Z configuration [20]. The large coupling constant (J = 11.0 Hz) between H-4a and H-11a suggested a trans-juncture of the two rings, which implied that H-4a was α-oriented. The NOESY correlations of H-4a with H-8, which presented quasi-axial on the α-face, and on the other hand, of H-11a with Me-18, exhibited a quasi-axial on the β-face as well as Me-18 and also showed correlation with H-9 revealed an α-orientation of the hydroxyl group at the C-9 position. Therefore, the structure of asterolaurin P was assigned as 2 based on the above results.
The molecular formula of C20H28O5 was deduced for asterolaurin Q (3) from its HRESIMS data, being consistent with 7 indices of hydrogen deficiency. The IR absorptions at 3420 and 1704 cm−1 indicated the presence of hydroxy and ester carbonyl groups, respectively. The NMR spectral data of 3 revealed a ring A similar to those of 1 because of an AB system of H2-1 at δH 4.09 (dd, 4.1, 11.0) and 3.91 (d, 11.0 Hz) was observed. The diene system, H-13 at δH 6.57 (dd, J= 11.8, 15.1 Hz), was coupled to H-12 (δH 7.04, d, J = 11.8 Hz) and H-14 (δH 6.35, d, J = 15.1 Hz), whereas the downfield shift of H-12 attributed to an anisotropy effect occurred with carbonyl group at C-3 that implied the E form configuration of Δ4,12 double bond in 3. In the aided DEPT spectra, 13C NMR resonances at δC 116.5 (CH2) and 120.1 (CH2) indicated the presence of two exo methylene double bonds, which were confirmed by the observation of four doublet signals at δH 4.84 (d, 1.8), 5.02 (d, 1.8), 5.10 (d, 1.6), and 5.20 (d, 1.6) in the 1H NMR spectrum. Besides, the presence of two oxygenated methines was deduced from the carbon signal at δC 83.1 and 70.5. corresponded to the proton signal at δH 3.97 (d, 9.0) and 4.06 (dd, 3.9, 9.0), respectively. The COSY spectrum (Figure 5) showed cross-peaks with signals at H-12/ H-13/ H-14; H-1 (δH 4.09, 3.91)/ H-11a (δH 2.46, m)/ H-4a (δH 3.17)/ H-5 (δH 1.84, m)/ H-6 (δH 1.92, m); H-8 (δH 3.97)/H-9 (δH 4.06)/ H-10 (δH 2.48, 2.60). Furthermore, the key HMBC correlations (Figure 5) of both H-1 and H-12 with C-3 (δC 171.4) and C-4a (δC 52.0), as well as H-13, H-14, Me-16 and Me-17 with C-15 (δC 76.5), allowed a δ-valerolactone ring linked with (via C-4) a diene which extended to an oxyquaternary carbon bearing two geminal methyls in 2. The HMBC correlations of H-6 with C-8, of H-10 with C-11a, of exomethylene protons (δH 5.10, 5.20, H-18) with C-6 and C-8, and of exomethylene protons (δH 5.02, 4.84, H-19) with C-10 and C-11a, allowed the construction of a cyclononane ring with two exomethylene functionalities at C-7 and C-11. Considering the molecular formula of 3 as well as the chemical shifts of C-8 (δC 83.1), C-9 (δC 70.5), and C-15 (δC 71.5), three hydroxy groups were attached at the abovementioned positions. Herein, the gross structure of 3 was assigned. The trans junction of the two rings was suggested by coupling constant (J = 9.2 Hz) between H-4a and H-11a, and the configuration of H-4a could be assumed as α-oriented. Additionally, the NOESY correlations (Figure 4) of H-19/H-4a/H-13 and also the correlations of H-5α/H-13/H-6α/H-18/H-8 revealed those protons were on the same α face of the structure. On the other hand, the NOESY cross-peaks of H-11a/H-5β/H-9 implied that H-9 was β-orientation. Therefore, the structure of asterolaurin P was assigned as 3 on the basis of the above results.
Compound 4 was isolated as an amorphous gum, and its molecular formula was established as C21H32O5 by HREIMS and NMR spectral data. The 1H and 13C NMR spectra of 4 showed some characteristic signals in the cyclononane skeleton as B ring moiety, similar to those of compounds 8 and 9. Two singlets at δH 5.11 and 4.85 corresponding to δC 144.8 were typical of resonances due to exocyclic methylene protons at C-19. A methyl-bearing E trisubstituted epoxide [δH 1.43 s, 3.00 (d, 8.0); δC 17.3 q, 59.2 s, 66.9 d], and epoxide proton (H-8) was further shown, and coupled with oxymethine [δH 3.80, dd (8.0, 7.4), δC 69.1] it implied a hydroxy group attached at the C-9 position. Moreover, bands for a diene olefinic system at δH 6.36 (d, 11.3, H-12), 6.44 (dd, 14.9, 11.3, H-13), and 5.84 (d,14.9, H-14) were also observed. COSY and HMBC correlations (Figure 6) supported the structure in which three spin fragments were connected in the aid of key HMBC corrections of Me-18 with C-6, C-7, and C-8, of H-19 with C-10, C-11, and C-11a, of an acetal proton H-3 (δH 5.17, brs; δC 99.2) with C-1, C-4, C-12, and methoxyl carbon (δC 55.1). Therefore, the structure of 4 could be established unambiguously. The 4(12) E-configuration and the E-geometry for Δ13 double bonds were determined by NOESY correlation (Figure 6) between H-13 and H-4a, and the coupling constant between H-13 and H-14 (14.9), respectively. Ring junction proton H-4a was assumed as an α-orientation, and H-11a was β-orientation due to the coupling constant between these two protons. On the β-face, H-11a showed the NOESY cross peak with Me-18, in turn coupled with H-9 revealed an α-orientation of hydroxyl group at the C-9 position. Besides, NOESY correlations of H-19A/H-4a/H-8 unveiled α-orientation of H-8. Based on the above results, we could infer that Me-18 was a β-quasi-axial orientation, whereas H-7 and H2-19 were α-quasi-axial orientations. Thus, the relative stereochemistry of the cyclononane ring system was similar to that of asterolaurin A [4]. Additionally, the NOESY correlations of H-3 with H2-5 showed β-quasi-axial orientation revealed α-orientation of methoxyl group at C-3 position. Thus the structure of asterolaurin R was unambiguously established as shown in Figure 6.
The cytotoxicities of all isolated marine natural products (110) were evaluated in vitro against human breast (MCF-7), oral (Ca9-22), and ovarian (SK-OV-3) carcinomas. As illustrated in Table 2, compounds 1 (IC50 = 14.7 μM) and 2 (IC50 = 25.1 μM) selectively possessed strong activities against the MCF-7 cell. For the ovarian and oral cancer cells, all tested xenicane diterpenoids were inactive (>100 μM).

3. Experimental

3.1. General

Optical rotations were determined using a JASCO P-2100 polarimeter (Jasco, Tokyo, Japan), and IR spectra were recorded on a JASCO FT/IR-4600 infrared spectrometer (Jasco, Tokyo, Japan). NMR spectra were recorded on Varian 600 MHz NMR (Varian, Palo Alto, CA, USA) and Bruker AVIII-HD700X 700 MHz spectrometers (Bruker, Bremen, Germany). HRESIMS data were recorded on a VG Biotech Quattro 5022 mass spectrometer (VG Biotech, Altrincham, UK). GNPS data were obtained on an Agilent 6545XT AdvanceBio LC/Q-TOF mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). Silica gel 60 (0.063–0.200 mm) was used for flash-column and open column chromatography (Merck KGaA, Darmstadt, Germany). Gel filtration column chromatography was performed with Sephadex LH-20 (GE Healthcare, Chicago, IL, USA). Precoated aluminum TLC plate/TLC silica gel 60 F254 were used for TLC analysis (Merck KGaA, Darmstadt, Germany). Normal-phase semi-preparative HPLC was accomplished using a Luna Silica (5 μm, 250 × 10 mm) column (Phenomenex, Torrance, CA, USA) on an L-6000 pump with an L-4000 UV detector (Hitachi, Tokyo, Japan), while reversed-phase HPLC was using Luna CN or Biphenyl (5 μm, 250 × 10 mm) columns (Phenomenex, Torrance, CA, USA) on a Chromaster 5110 pump with a Chromaster 5410 UV detector (Hitachi, Tokyo, Japan).

3.2. Animal Material

Specimens of soft coral Asterospicularia laurae were donated by Prof. Ya-Ching Shen in 2019. The animal materials were collected in August 2012 off the coast of Orchid Island, Taiwan. The samples were stored in a freezer until extraction. The material was identified by Prof. Dr. Jui-Hsin Su. A voucher sample (specimen code: AL001) was deposited at Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan.

3.3. Global Natural Product Social Molecular Networking

Equal divisions (10 μL) of the MeOH-layer of Taiwanese soft coral A. laurae were dispensed into 96-well plates, dried under nitrogen, and resuspended in DMSO (10 μL), and 10 μL of a DMSO aliquot was injected into an Agilent 6545XT AdvanceBio LC/Q-TOF (quadrupole time-of-flight) equipped with an Agilent 1290 Infinity II LC system, eluting with an ACQUITY UPLC BEH C18 column (1.7 μm, 2.1 × 100 mm, flow rate: 0.4 mL/min, Waters). The elution program, using water (A) and acetonitrile (B), both with 0.1% formic acid as mobile phases, started with a 5% isocratic elution for 1 min and was then followed by a linear gradient from 5% to 99.5% B until 16 min, and then maintained 99.5% B as a solvent system for 10 min followed by re-equilibration period for 2 min before the next injection. The UPLC-Q-TOF-(-)MS/MS data acquired for all samples at a fixed collision energy of 40 eV were converted from RAW data files to mzXML file format using the ProteoWizard MSconvert software [23] and uploaded to the Global Natural Products Social Molecular Networking Web server to create a molecular network [24]. The resulting spectral networks were imported into Cytoscape version 3.8.2 [25]. Careful review of these GNPS data associated with the Comprehensive Marine Natural Products Database and Reaxys® database highlighted a promising cluster (Figure 1 and Figure S45), as a possible source of new xenicane diterpenoids.

3.4. Extraction and Isolation

Soft coral Asterospicularia laurae (115.4 g, wet weight) was macerated with 95% ethanol (1.5 L, 3 times) at room temperature. The solvent was decanted and the extract was concentrated under reduced pressure to obtain a crude extract (31.4 g), which was partitioned between H2O and ethyl acetate to yield an ethyl acetate layer. The EtOAc layer was subsequently partitioned (hexanes/MeOH/H2O = 4:3:1) to obtain hexanes and MeOH layers. After 1H NMR, experiments were co-referred with TLC assay as well as GNPS MS/MS analysis on all obtained layers, and the MeOH layer was selected for further isolation. The MeOH layer (5.2 g) was chromatographed by a normal-phase silica gel flash column eluted with a gradient solvent system of hexanes and ethyl acetate (5:1~0:1) followed by stepwise ethyl acetate with methanol (20:1~0:1) to obtain six subfractions (LA1~6), according to TLC analysis. The third sub-fraction, LA3, was fractionated over Sephadex LH-20 using MeOH and CH2Cl2 (1:1) as a solvent to afford six subfractions (LA3-1~6). Fraction LA-3-5 was purified by normal-phase HPLC (hexane/dichloromethane/methanol, 50:45:5) to yield compounds 1 (2.7 mg), 3 (1.4 mg), 9 (1.6 mg), and 10 (2.3 mg). Fraction LA-3-4 was subjected to silica gel CC (CH2Cl2/MeOH, 1:0→0:1) to get five subfractions (LA3-4-1~5), and subfraction LA3-4-4 was further separated by normal-phase HPLC (hexane/dichloromethane/methanol, 57:38:5) to afford compounds 4 (1.4 mg), 7 (1.3 mg), and 8 (2.1 mg). Besides, Fr. LA3-4-3 was isolated by reverse-phase HPLC using a CN column and gave compound 2 (1.7 mg) along with two subfractions Fr. LA-3-4-3-1~2. The fraction LA-3-4-3-1 was isolated by RP-Biphenyl HPLC (methanol/H2O, 60/40) to give compounds 5 (0.5 mg) and 6 (0.5 mg).

3.5. Spectroscopic Data

  • Asterolaurin O (1) amorphous, colorless gum, [ α ] D 26 −1.0° (c 0.05, MeOH); IR (neat) νmax 3424, 2960, 2929, 1719, 1379, 1261, 1167, 1033 cm−1; 1H-NMR and 13C-NMR (CD3OD, 700/175 MHz) see Table 1; HRESIMS m/z 451.10903 (calcd for C20H29BrNaO5, 451.10906).
  • Asterolaurin P (2) pale yellowish amorphous gum, [ α ] D 26   −47.6° (c 0.05, MeOH); IR (neat) νmax 3454, 2926, 1727, 1455, 1263, 1029 cm−1; 1H-NMR and 13C-NMR (CD3OD, 600/150 MHz) see Table 1; HRESIMS m/z 369.20379 (calcd for C21H30O4Na, 369.20363).
  • Asterolaurin Q (3) amorphous, colorless gum, [ α ] D 26 −1.0° (c 0.05, MeOH); IR (neat) νmax 3420, 2962, 2927, 2360, 1703, 1638, 1261, 1091 cm−1; 1H-NMR and 13C-NMR (CD3OD, 700/175 MHz) see Table 1; HRESIMS m/z 371.18294 (calcd for C20H28O5Na, 371.18290).
  • Asterolaurin R (4) amorphous, colorless gum, [ α ] D 26 −47.6° (c 0.05, MeOH); IR (neat) νmax 3433, 2964, 1643, 1260, 1072 cm−1; 1H-NMR and 13C-NMR (CDCl3, 600/150 MHz) see Table 1; HRESIMS m/z 387.21425 (calcd for C21H32O5Na, 387.21420).

3.6. Cytotoxic Assays

Breast (MCF-7), oral (Ca9-22), and ovarian (SK-OV-3) cancer cell lines were available from the American Type Culture Collection (ATCC, Manassas, VA, USA) or the Japanese Collection of Research Bioresources (JCRB) Cell Bank (National Institute of Biomedical Innovation, Osaka, Japan). The cell viability was detected by MTS assay at 72 h treatment as previously described [24].

4. Conclusions

With the assistance of molecular networking-based de-replication strategy, xenicane diterpenes were targeted and obtained from the marine soft coral A. laurae. Among ten isolated compounds, asterolaurins O–Q (13) were identified as new xeniolides (possessing a δ-lactone-cyclononane skeleton), and asterolaurin R (4) was a new xenicin (containing an 11-oxabicyclo[7.4.0]tridecane ring system with an acetal functionality). It is noteworthy that asterolaurin O (1) was the first case of natural brominated tricarbocyclic floridicins yielded from the family Xeniidae. Moreover, compared with other asterolaurins obtained from the genus Asterospicularia, asterolaurin O (1) showed potent inhibition toward MCF-7 cells. This finding suggests that brominated xenicane-type diterpenes were worthy for further cytotoxic evaluations.

Supplementary Materials

The HRESIMS, IR spectra, 1H, 13C, DEPT, HSQC, COSY, HMBC, and NOESY spectra of compounds 14 are available online at https://www.mdpi.com/1660-3397/19/3/123/s1, Figure S1. The HRESIMS of asterolaurin O (1); Figure S2. The IR spectrum of asterolaurin O (1); Figure S3. The 1H-NMR spectrum of asterolaurin O (1) (700 MHz in CD3OD); Figure S4. The 1H-NMR spectrum (0.5-2.5 ppm) of asterolaurin O; Figure S5. The 13C-NMR spectrum of asterolaurin O (1) (175 MHz in CD3OD); Figure S6. The 13C-NMR spectrum (20-55 ppm) of asterolaurin O (1); Figure S7. The DEPT spectrum of asterolaurin O (1); Figure S8. The 1H-1H COSY spectrum of asterolaurin O (1); Figure S9. The HSQC spectrum of asterolaurin O (1); Figure S10. The HMBC spectrum of asterolaurin O (1); Figure S11. The NOESY spectrum of asterolaurin O (1); Figure S12. The HRESIMS of asterolaurin P (2); Figure S13. The IR spectrum of asterolaurin P (2); Figure S14. The 1H-NMR spectrum of asterolaurin P (2) (600 MHz in CD3OD); Figure S15. The 1H-NMR spectrum (0.5-2.5 ppm) of asterolaurin P; Figure S16. The 13C-NMR spectrum of asterolaurin P (2) (150 MHz in CD3OD); Figure S17. The 13C-NMR spectrum (15-55 ppm) of asterolaurin P (2); Figure S18. The DEPT spectra of asterolaurin P (2); Figure S19. The 1H-1H COSY spectrum of asterolaurin P (2); Figure S20. The HSQC spectrum of asterolaurin P (2); Figure S21. The HMBC spectrum of asterolaurin P (2); Figure S22. The NOESY spectrum of asterolaurin P (2); Figure S23. The HRESIMS of asterolaurin Q (3); Figure S24. The IR spectrum of asterolaurin Q (3); Figure S25. The 1H-NMR spectrum of asterolaurin Q (3) (700 MHz in CD3OD); Figure S26. The 1H-NMR spectrum (0.5-2.5 ppm) of asterolaurin Q; Figure S27. The 13C-NMR spectrum of asterolaurin Q (3) (175 MHz in CD3OD); Figure S28. The 13C-NMR spectrum (20-55 ppm) of asterolaurin Q; Figure S29. The DEPT spectrum of asterolaurin Q (3); Figure S30. The 1H-1H COSY spectrum of asterolaurin Q (3); Figure S31. The HSQC spectrum of asterolaurin Q (3); Figure S32. The HMBC spectrum of asterolaurin Q (3); Figure S33. The NOESY spectrum of asterolaurin Q (3); Figure S34. The HRESIMS of asterolaurin R (4); Figure S35. The IR spectrum of asterolaurin R (4); Figure S36. The 1H-NMR spectrum of asterolaurin R (4) (600 MHz in CDCl3); Figure S37. The 1H-NMR spectrum (0.5-2.5 ppm) of asterolaurin R; Figure S38. The 13C-NMR spectrum of asterolaurin R (4) (150 MHz in CDCl3); Figure S39. The 13C-NMR spectrum (15-55 ppm) of asterolaurin R; Figure S40. The DEPT spectra of asterolaurin R; Figure S41. The 1H-1H COSY spectrum of asterolaurin R (4); Figure S42. The HSQC spectrum of asterolaurin R (4); Figure S43. The HMBC spectrum of asterolaurin R (4); Figure S44. The NOESY spectrum of asterolaurin R (4); Figure S45. Negative Q-TOF MS/MS spectrum of xeniolide-A (5).

Author Contributions

Conceptualization, Y.-B.C. and C.-Y.C.; validation, S.-R.C.; investigation, Y.-C.L., Y.-J.C., W.-J.L. and H.-W.C.; resources, Y.-L.Y., C.-C.L. and J.-H.S.; writing—original draft preparation, Y.-C.L.; writing—review and editing, Y.-B.C. and S.-R.C.; funding acquisition, Y.-B.C. and C.-Y.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Science and Technology of Taiwan (MOST 108-2320-B-110-009-MY3).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020, 83, 770–803. [Google Scholar] [CrossRef]
  2. Ksebati, M.B.; Schmitz, F.J. 24ξ-Methyl-5α-cholestane-3β,5,6β,22R,24-pentol 6-acetate: New polyhydroxylated sterol from the soft coral Asterospicularia randalli. Steroids 1984, 43, 639–649. [Google Scholar] [CrossRef]
  3. Bowden, B.; Cusack, B.; Dangel, A. 13-Epi-9-deacetoxyxenicin, a cytotoxic diterpene from the Soft Coral Asterospicularia laurae (Alcyonacea). Mar. Drugs 2003, 1, 18–26. [Google Scholar] [CrossRef] [Green Version]
  4. Lin, Y.-C.; El-Razek, M.H.A.; Hwang, T.-L.; Chiang, M.Y.; Kuo, Y.-H.; Dai, C.-F.; Shen, Y.-C. Asterolaurins A−F, xenicane diterpenoids from the Taiwanese soft coral Asterospicularia laurae. J. Nat. Prod. 2009, 72, 1911–1916. [Google Scholar] [CrossRef] [PubMed]
  5. Lin, Y.-S.; Fazary, A.E.; Chen, C.-H.; Kuo, Y.-H.; Shen, Y.-C.; Asterolaurins, G.-J. New xenicane diterpenoids from the Taiwanese soft coral Asterospicularia laurae. Helv. Chim. Acta 2011, 94, 273–281. [Google Scholar] [CrossRef]
  6. Lin, Y.-S.; Fazary, A.E.; Chen, C.-H.; Kuo, Y.-H.; Shen, Y.-C. Bioactive xenicane diterpenoids from the Taiwanese soft coral Asterospicularia laurae. Chem. Biodiv. 2011, 8, 1310–1317. [Google Scholar] [CrossRef]
  7. Su, J.-H.; Liu, C.-I.; Lu, M.-C.; Chang, C.-I.; Hsieh, M.-Y.; Lin, Y.-C.; Dai, C.-F.; Zhang, Y.-H.; Lin, Z.-Y.; Lin, Y.-S. New secondary metabolite with cytotoxicity from spawning soft coral Asterospicularia laurae in Taiwan. Nat. Prod. Res. 2019, 1–9. [Google Scholar] [CrossRef]
  8. Watrous, J.; Roach, P.; Alexandrov, T.; Heath, B.S.; Yang, J.Y.; Kersten, R.D.; van der Voort, M.; Pogliano, K.; Gross, H.; Raaijmakers, J.M.; et al. Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. USA 2012, 109, 1743–1752. [Google Scholar] [CrossRef] [Green Version]
  9. Allard, P.-M.; Péresse, T.; Bisson, J.; Gindro, K.; Marcourt, L.; Pham, V.C.; Roussi, F.; Litaudon, M.; Wolfender, J.-L. Integration of molecular networking and in-silico ms/ms fragmentation for natural products de-replication. Anal. Chem. 2016, 88, 3317–3323. [Google Scholar] [CrossRef]
  10. Chao, R.; Hou, X.-M.; Xu, W.-F.; Hai, Y.; Wei, M.-Y.; Wang, C.-Y.; Gu, Y.-C.; Shao, C.-L. Targeted Isolation of Asperheptatides from a Coral-Derived Fungus Using LC-MS/MS-Based Molecular Networking and Antitubercular Activities of Modified Cinnamate Derivatives. J. Nat. Prod. 2021, 84, 11–19. [Google Scholar] [CrossRef]
  11. Kashman, Y.; Groweiss, A. Xeniolide-A and xeniolide-B, two new diterpenoids from the soft-coral xenia macrospiculata. Tetrahedron Lett. 1978, 48, 4833–4836. [Google Scholar] [CrossRef]
  12. Braekman, J.C.; Daloze, D.; Tursch, B.; Declercq, J.P.; Germain, G.; Meerssche, M.V. Chemical Studies of Marine Invertebrates. XXXIX. Three novel diterpenoids from the soft coral Xenia novae-britanniae. Bull. Soc. Chim. Belg. 1979, 88, 71–77. [Google Scholar] [CrossRef]
  13. Kashman, Y.; Groweiss, A. New diterpenoids from the soft corals Xenia macrospiculata and Xenia obscuronata. J. Org. Chem. 1980, 45, 3814–3824. [Google Scholar] [CrossRef]
  14. Anta, C.; González, N.; Santafé, G.; Rodríguez, J.; Jiménez, C. New xenia diterpenoids from the Indonesian soft coral Xenia sp. J. Nat. Prod. 2002, 65, 766–768. [Google Scholar] [CrossRef] [PubMed]
  15. Iwagawa, T.; Kawasaki, J.-I.; Hase, T. New xenia diterpenes isolated from the soft coral, Xenia florida. J. Nat. Prod. 1998, 61, 1513–1515. [Google Scholar] [CrossRef]
  16. Iwagawa, T.; Kawasaki, J.-I.; Hase, T.; Wright, J.L. New di- and tricarbocyclic diterpenes possessing a bicyclic [4.3.1] ring system isolated from the soft coral, Xenia florida. Tetrahedron 1997, 53, 6809–6816. [Google Scholar] [CrossRef]
  17. Iwagawa, T.; Kawasaki, J.-I.; Hase, T.; Yu, C.-M.; Walter, J.A.; Wright, J.L.C. A new tricarbocyclic diterpene structure from the soft coral Xenia florida. J. Chem. Soc. Chem. Com. 1994, 2073–2074. [Google Scholar] [CrossRef]
  18. El-Gamal, A.A.H.; Chiang, C.-Y.; Huang, S.-H.; Wang, S.-K.; Duh, C.-Y. Xenia diterpenoids from the formosan soft coral Xenia blumi. J. Nat. Prod. 2005, 68, 1336–1340. [Google Scholar] [CrossRef]
  19. El-Gamal, A.A.H.; Wang, S.-K.; Duh, C.-Y. Cytotoxic xenia diterpenoids from the soft coral Xenia umbellata. J. Nat. Prod. 2006, 69, 338–341. [Google Scholar] [CrossRef]
  20. Couperus, P.A.; Clague, A.D.H.; Van Dongen, J.P.C.M. 13C chemical shifts of some model olefins. Org. Mag. Reson. 1976, 8, 426–431. [Google Scholar] [CrossRef]
  21. Ou-Yang, F.; Tsai, I.-H.; Tang, J.-Y.; Yen, C.-Y.; Cheng, Y.-B.; Farooqi, A.A.; Chen, S.-R.; Yu, S.-Y.; Kao, J.-K.; Chang, H.-W. Antiproliferation for Breast Cancer Cells by Ethyl Acetate Extract of Nepenthes thorellii x (ventricosa x maxima). Int. J. Mol. Sci. 2019, 20, 3238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zhang, X.; Samadi, A.K.; Roby, K.F.; Timmermann, B.; Cohen, M.S. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol. Oncol. 2012, 124, 606–612. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Kessner, D.; Chambers, M.; Burke, R.; Agus, D.; Mallick, P. ProteoWizard: Open source software for rapid proteomics tools development. Bioinformatics 2008, 24, 2534–2536. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef]
Figure 1. Cluster (left: molecular weight and proposed name; right: proposed chemical structure) of the xenicane-type diterpenes from the extract of A. laurae.
Figure 1. Cluster (left: molecular weight and proposed name; right: proposed chemical structure) of the xenicane-type diterpenes from the extract of A. laurae.
Marinedrugs 19 00123 g001
Figure 2. Structures of compounds 110 isolated from A. laurae.
Figure 2. Structures of compounds 110 isolated from A. laurae.
Marinedrugs 19 00123 g002
Figure 3. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 1.
Figure 3. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 1.
Marinedrugs 19 00123 g003
Figure 4. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 2.
Figure 4. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 2.
Marinedrugs 19 00123 g004
Figure 5. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 3.
Figure 5. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 3.
Marinedrugs 19 00123 g005
Figure 6. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 4.
Figure 6. COSY (bold bond), selected HMBC (arrow), and NOESY (left-right arrow) correlations of 4.
Marinedrugs 19 00123 g006
Table 1. 1H-NMR and 13C-NMR data for compounds 14.
Table 1. 1H-NMR and 13C-NMR data for compounds 14.
1 b2 a3 b4 c
δH (J in Hz)δcδH (J in Hz)δcδH (J in Hz)δcδH (J in Hz)δc
1 176.9, s4.11, dd (5.9, 11.3)72.4, t4.09, dd (4.1, 11.0)71.5, t3.61, dd (6.5, 11.5)65.9, t
3.63, t (11.3) 3.91, t (11.0) 3.28, t (11.5)
34.44, d (12.0)73.2, t 171.4, s 172.2, s5.17, brs99.2, d
5.06, d (12.0)
4 137.0, s 134.6, s 133.3, s 138.5, s
4a3.18, t (12.0)39.3, d2.70, dt (2.9, 11.0)52.0, d3.17, t (9.2)42.8, d2.97, brd (11.5)43.1, d
51.95, m33.4, t1.61, m39.1, t1.84, m38.5, t1.61, m34.8, t
1.87, m 1.83, m
6α2.08, m40.8, t2.19, m40.9, t1.92, m31.0, t2.20, t (3.6)40.5, t
6β1.82, m 2.22, t (3.6)
7 37.4, s 133.2, s 149.0, s 59.2, s
84.09, d (5.7)71.2, d5.26, d (7.4)131.8, d3.97, d (9.0)83.1, d3.00, d (8.0)66.9, d
94.37, td (5.7, 8.7)75.1, d4.72, t (7.4)67.9, d4.06, dd (3.9, 9.0)70.5, d3.80, dd (8.0, 7.4)69.1, d
10α2.24, d (8.7)39.8, t2.34, d (13.6)46.2, t2.48, m45.0, t2.45, m44.7, t
10β2.22, d (5.7) 2.50, dd (13.6, 6.4) 2.60, m 2.47, t (7.4)
11 72.5, s 149.5, s 148.3, s 147.4, s
11a2.88, d (12.0)57.3, d2.06, dd (5.9, 11.0)51.1, d2.46, m44.7, d2.26, dd (6.5, 11.5)50.7, d
126.15, d (11.1)129.7, d6.53, d (11.0)137.3, d7.04, d (11.8)140.4, d6.36, d (11.3)126.5, d
136.34, dd (11.1, 15.3)122.3, d6.76, dd (11.0, 15.7)126.6, d6.57, dd (11.8, 15.1)121.7, d6.44, dd (11.3,14.9)120.4, d
145.94, d (15.3)146.2, d5.98, d (15.7)146.4, d6.35, d (15.1)153.2, d5.97, d (14.9)144.6, d
15 71.3, s 76.5, s 71.5, s 71.0, s
161.30, s29.8, q1.30, s26.0, q1.34, s29.7, q1.32, s29.9, q
171.30, s29.8, q1.30, s25.9, q1.34, s29.7, q1.32, s29.9, q
181.15, s34.7, q1.70, s17.3, q5.20, d (1.6)120.2, t1.44, s17.3, q
5.10, d (1.6)
19A1.76, d (14.6)44.7, t5.06, s115.3, t5.02, d (1.8)116.5, t4.85, s114.8, t
19B1.84, d (14.6) 4.95, s 4.84, d (1.8) 5.11, s
OH4.61, brs
OMe 3.16, s50.9, q 3.47, s55.1, q
a 1H and 13C-NMR were measured in MeOH-d4 at 600 and 150 MHz, respectively. b 1H and 13C-NMR were measured in MeOH-d4 at 700 and 175 MHz, respectively. c 1H and 13C-NMR were measured in CDCl3 at 600 and 150 MHz, respectively.
Table 2. Results of Cytotoxicities (IC50, µM) of isolated compounds 110.
Table 2. Results of Cytotoxicities (IC50, µM) of isolated compounds 110.
Compound/Tumor CellsMCF-7Ca9-22SK-OV-3
114.7 ± 0.23>100>100
225.1 ± 4.1>100>100
3>100>100>100
4>100>100>100
5>100>100>100
6>100>100>100
7>100>100>100
8>100>100>100
9>100>100>100
10>100>100>100
Cisplatin a19.8 13.8
a Positive control; data come from literatures [21,22].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lin, Y.-C.; Chen, Y.-J.; Chen, S.-R.; Lien, W.-J.; Chang, H.-W.; Yang, Y.-L.; Liaw, C.-C.; Su, J.-H.; Chen, C.-Y.; Cheng, Y.-B. Targeted Isolation of Xenicane Diterpenoids From Taiwanese Soft Coral Asterospicularia laurae. Mar. Drugs 2021, 19, 123. https://doi.org/10.3390/md19030123

AMA Style

Lin Y-C, Chen Y-J, Chen S-R, Lien W-J, Chang H-W, Yang Y-L, Liaw C-C, Su J-H, Chen C-Y, Cheng Y-B. Targeted Isolation of Xenicane Diterpenoids From Taiwanese Soft Coral Asterospicularia laurae. Marine Drugs. 2021; 19(3):123. https://doi.org/10.3390/md19030123

Chicago/Turabian Style

Lin, Yu-Chi, Yi-Jen Chen, Shu-Rong Chen, Wan-Ju Lien, Hsueh-Wei Chang, Yu-Liang Yang, Chia-Ching Liaw, Jui-Hsin Su, Ching-Yeu Chen, and Yuan-Bin Cheng. 2021. "Targeted Isolation of Xenicane Diterpenoids From Taiwanese Soft Coral Asterospicularia laurae" Marine Drugs 19, no. 3: 123. https://doi.org/10.3390/md19030123

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop